Transcript · Doug Young, Desjardins · Stop-loss
What drove the year-over-year improvement in U.S. medical stop-loss and is it sustainable into 2027?
Earnings were up 45% after adjusting for the Q3'25 reserve change, driven mainly by volume from higher sales and persistency, with claims in line with expectations and a strong Q4 and 1/1 pipeline. — David Healy
Transcript · Doug Young, Desjardins · Dental policy
How does the U.S. political change affect the Medicaid and dental outlook, and is there further intangible write-down risk?
It is too early to tell on policy, and goodwill testing happens in Q4, with only non-material customer relationship intangible exposure from exiting unprofitable contracts. — David Healy, Tim Deacon
Transcript · Alex Scott, Barclays · Disability
What are you seeing in disability claims and what do you expect for Q4 and 2027?
Long-term disability incidence and severity were elevated, including mental health claims, in line with the industry, and Sun Life is focused on return-to-work, pricing and expense management. — David Healy
Transcript · Alex Scott, Barclays · MFS flows
What is the outlook for MFS flows given industry headwinds?
Outflows are driven by a shift to passive as concentrated indices outperform active managers, and management expects those trends to persist. — Ted Maloney
Transcript · Gabriel Dechaine, National Bank Financial · Canada group
Why is Canadian group disability experience holding up and does it need repricing?
Management credits disciplined pricing and operational actions and says experience remains within the normal range of variation. — Jessica Tan
Transcript · Gabriel Dechaine, National Bank Financial · U.S. morbidity
How much of the U.S. experience loss was LTD and is AI-related job loss a factor?
The morbidity loss was predominantly LTD, seen in health care and manufacturing, and AI cannot be pointed to as a driver at this point. — David Healy
Transcript · Tom MacKinnon, BMO · Expenses
Is the lower expense line sustainable?
Expense discipline is broad-based and much of it is sustainable following the restructuring program, though incentive accruals cause quarterly fluctuation. — Tim Deacon
Transcript · Tom MacKinnon, BMO · Canada wealth fees
Is the jump in Canada's other fee income sustainable?
About 80% of the line is wealth net fee income, which should grow at least with AUMA plus scale benefits. — Jessica Tan
Transcript · Mario Mendonca, BofA Securities · MFS expenses
Can MFS cut expenses as fast as assets fall if average assets decline high single digits?
About two-thirds of costs are variable, but MFS will keep investing for clients so negative operating leverage is possible short term. — Ted Maloney
Transcript · Mario Mendonca, BofA Securities · U.S. health care
Does U.S. health care still make sense inside Sun Life and how much of U.S. earnings does it represent?
Management says Employee Benefits and stop-loss remain core pillars while dental is repositioned, and they make up basically all U.S. earnings other than In-force Management. — Kevin Strain, David Healy
Transcript · Paul Holden, CIBC · Asia growth
Is Asia now a mid-single-digit grower and how does it return to double digits?
Q3'25 joint venture security gains skew the comparison, year-to-date earnings are up 14%, and management is comfortable with double-digit growth ahead. — Manjit Singh
Transcript · Paul Holden, CIBC · Interest rates
Are you shifting securities to capture higher interest rates?
No, Sun Life closely matches assets and liabilities and is not taking interest rate bets. — Randy Brown
Transcript · Mike Rizvanovic, Scotiabank · LTD repricing
How does the U.S. LTD repricing timeline work?
At least half of business renews 1/1 on two-to-three-year contracts, so repricing affects about one-third of premium each year. — David Healy
Transcript · Mike Rizvanovic, Scotiabank · Disability risk
What is the risk of similarly large disability losses in coming quarters?
Experience is expected to remain elevated near term, but it is too early to say how long it will persist. — David Healy, Kevin Strain
Transcript · Mike Rizvanovic, Scotiabank · U.S. expenses
How far along is U.S. expense mitigation?
Expense discipline is a core priority and has been demonstrated in recent quarters, particularly in dental, and will continue. — David Healy
Transcript · Bart Dziarski, RBC · GreenOak margins
Is a high-20s fee-related earnings margin right for GreenOak?
No, the target is 35% plus, to be reached through integration synergies, AUM growth and expense management. — Sonny Kalsi
Transcript · Bart Dziarski, RBC · ROE target
Is the 20% ROE target now a stretch?
Management retains conviction in the medium-term objective, with Canada, Asia and GreenOak contributing more than originally laid out and U.S. less. — Tim Deacon
Transcript · Thomas Gallagher, Evercore · Disability differences
Why is Canadian disability holding up better than the U.S.?
Market structure differs, including U.S. two-year mental health limits and Canada's longer-duration contracts, and Sun Life typically serves whole benefit programs in Canada. — David Healy, Jessica Tan, Kevin Strain
Transcript · Thomas Gallagher, Evercore · Stop-loss 2027
How are you feeling about stop-loss pricing and growth into January 2027 renewals?
Management sees a large pipeline, a good pricing position and expects the market to remain hardened through the 1/1 cycle. — David Healy